Menu Menu

AVXL    Anavex Life Sciences Corp    1314052    
Income Statement
Net Income -12,111,000

Balance Sheet
Assets 124,043,000
Liabilities 13,128,000
Equity 110,915,000
Shares Out 92,672,000

Cash Flow Statement
Operating Cash Flow -12,120,000

Market Analysis
Market Cap 334,544,971
Price 3.61
BVPS 1.31
PB 7.48
EPS -0.46
PS 2.89
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/12 -0.14
Apr May Jun
5/09 -0.13
Jul Aug Sep
8/06 -0.14
Oct Nov Dec
11/25

Find a discrepancy? The most accurate way to find company fundamental data is to view AVXL documents filed with the SEC.


AVXL Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: